EU-Perjeta
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EU-Perjeta, covering 2025-06-10 to 2025-06-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer [Phase 3]